Literature DB >> 19615316

Serum proteomes of hypertension patients with abundant phlegm-dampness.

Yu-guang Chu1, Jie Shi, Yuan-hui Hu, Hua-qin Wu, Gui-jian Liu, Chao-jun Hu, Yong-zhe Li, Yi Li, Zi-jing Chen, Qing He.   

Abstract

OBJECTIVE: To study the serum proteomes of essential hypertension (EH) patients with abundant phlegm-dampness, and try to find special proteins associated with abundant phlegm-dampness syndrome.
METHODS: Fifty-nine hypertension patients were included, and the patients were divided into abundant phlegm-dampness syndrome group (39 cases) and non-phlegm-dampness syndrome group (20 cases). To find the special proteins associated with abundant phlegm-dampness, the EH patients with non-phlegm-dampness and another 30 healthy persons were regarded as control. Weak cation nano-magnetic beads were used to capture proteins in serum, and proteomic fingerprint was made by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). All the proteomic fingerprints were analyzed by Biomarker Wizard 3.1 Software. Then Biomarker Patterns Software (BPS) 5.0 was used to identify the differentiated proteins, which could induce phlegm-dampness.
RESULTS: There were 102 differentiated protein peaks between abundant phlegm-dampness and the control group. The best markers of abundant phlegm-dampness were protein peaks with the mass to charge ratio (m/z) of 9,334.958 m/z (the expression increased), 9,280.191 m/z (the expression decreased), 8,030.794 m/z (the expression increased), and 2,941.551 m/z (the expression increased). These four protein peaks found by BPS could induce abundant phlegm-dampness. They could be used to separate the abundant phlegm-dampness syndrome from the healthy persons and the hypertension patients with non-phlegm-dampness. The sensitivity of the model was 93.103% (27/29), specificity was 92% (23/25), false positive rate was 8% (2/25), false negative rate was 6.897% (2/29) and Youden's index was 85.103%. Blind test data indicated a sensitivity of 90% (9/10) and a specificity of 88% (22/25), and the false positive rate was 12% (3/25), false negative rate was 10% (1/10), and Youden's index was 78%.
CONCLUSION: The differentiated proteins between the abundant phlegm-dampness group and the control group are the material foundation of abundant phlegm-dampness. The selected differentiated proteins can be used to distinguish the EH patients with abundant phlegm-dampness from the healthy persons and the EH patients with non-phlegm-dampness. The molecular biology diagnosis model can offer an objective and accurate way for TCM syndrome differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615316     DOI: 10.3736/jcim20090706

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  7 in total

Review 1.  Chinese medicine pattern differentiation and its implications for clinical practice.

Authors:  Arthur Sá Ferreira; Agnaldo José Lopes
Journal:  Chin J Integr Med       Date:  2011-11-06       Impact factor: 1.978

2.  Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension.

Authors:  Alexandre Bastos Luiz; Arthur Sá Ferreira; Ivan Cordovil; José Barbosa Filho
Journal:  Chin Med       Date:  2011-06-17       Impact factor: 5.455

3.  The Quintessence of Traditional Chinese Medicine: Syndrome and Its Distribution among Advanced Cancer Patients with Constipation.

Authors:  Chung-Wah Cheng; Annie O L Kwok; Zhao-Xiang Bian; Doris M W Tse
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-24       Impact factor: 2.629

4.  Clinical Applications of Omics Technologies on ZHENG Differentiation Research in Traditional Chinese Medicine.

Authors:  Ya-Nan Song; Gui-Biao Zhang; Yong-Yu Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

Review 5.  Recent Advances and Perspective of Studies on Phlegm Syndrome in Chinese Medicine.

Authors:  Zhiguo Zhang; Jingqing Hu
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-14       Impact factor: 2.629

6.  Weight changes in hypertensive patients with phlegm-dampness syndrome: an integrated proteomics and metabolomics approach.

Authors:  Chi Zhang; Li Li; Shiping Cheng; Debajyoti Chowdhury; Yong Tan; Xinru Liu; Ning Zhao; Xiaojuan He; Miao Jiang; Cheng Lu; Aiping Lyu
Journal:  Chin Med       Date:  2021-07-07       Impact factor: 5.455

Review 7.  Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research.

Authors:  Qing Ji; Fangshi Zhu; Xuan Liu; Qi Li; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.